Clinical Study Validates H3.1 Nucleosomes as Sepsis Biomarker
A study validates Nu.Q NETs H3.1 nucleosomes as independent predictors of 28-day mortality and renal replacement therapy need in sepsis and septic shock, according to VolitionRx.
Category: Sepsis
Sepsis
Latest
Sepsis
Latest
Inflammatix Publishes Data Supporting TriVerity Test System Performance in Sepsis
Journal of Clinical Microbiology study validates accuracy, precision and operational usability of FDA-cleared sepsis diagnostic test.
Sepsis
Latest
Sepsis Screening Improves Redesigned VSNO deviceÂ
Vail Scientific, in partnership with Minnetronix, has unveiled a newly designed VSNO sepsis screening device that enhances usability.
Test Can Predict Neonatal Sepsis Before Symptoms Show
A genetic signature in newborns can predict neonatal sepsis before symptoms appear, according to a new study by UBC and SFU researchers.
Read More
Hardy Diagnostics and Gradientech to Distribute Antibiotic Sensitivity Testing System for Sepsis
The QuickMIC system aims to improve sepsis care by enabling faster, more accurate antibiotic treatment decisions.
Read More
Ad Astra Gets Federal Contract to Advance CBC Diagnostics for Sepsis Detection
The $5 million contract will help develop a diagnostic system that delivers fast CBC results and improves early detection for sepsis.
Read More
New Microfluidic Chip Tech Offers Improved Sepsis Prognosis
A microfluidic chip-based method assesses sepsis severity by analyzing immune cell migration: a new approach to diagnosis and prognosis.
Read More
Abionic’s IVD Sepsis Detection Test Receives FDA 510(k) ClearanceÂ
Abionic’s IVD CAPSULE PSP test gained FDA 510(k) clearance to rapidly detect sepsis, marking the company’s expansion into the U.S. market.
Read More
Cytovale Expands FDA-Cleared Sepsis Detection Test to Wisconsin Health Network
The Froedtert & Medical College of Wisconsin will screen patients in their network with the IntelliSep test for early sepsis detection.
Read More
Machine Learning Could Revolutionize Diagnosis of Multiple Myeloma and Sepsis
Advances in AI and data science highlight innovative machine learning models that predict patient outcomes in multiple myeloma and sepsis.
Read More
Cytovale’s Sepsis Diagnostic Triages First 5,000 Patients
Cytovale’s IntelliSep test helped support the sepsis management program for Our Lady of the Lake Regional Medical Center.
Read More
AI Enables Effective Antibiotic Treatment of Sepsis
AI-based antimicrobial susceptibility test method promises rapid prediction of antimicrobial resistance using blood of sepsis patients.
Read More
Nasal Microbiota is a Potential Sepsis Diagnostic Biomarker
A new study reveals that the nasal microbiota of ICU patients is more effective than gut microbiota in distinguishing sepsis from non-sepsis.
Read More
Bruker Expands Clinical Microbiology and Infection Diagnostics Portfolio
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Read More
Software for Rapid Sepsis Diagnosis Gets FDA De Novo Marketing Authorization
The Sepsis ImmunoScore is an AI/machine learning software as a medical device to guide rapid diagnosis and prediction of sepsis.Â
Read More
Cytovale’s Sepsis Test Shows Improved Patient Care and Cost Savings
Find out how Cytovale’s IntelliSep test reduced cost of care and improved the efficiency of sepsis care for a large U.S. academic center.
Read More
New Analysis Method Melts DNA to Detect Pathogens Faster
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.
Read More
New Sepsis Test Provides Faster and Reliable Results
Doctors from Norway received test results two days earlier than before when they tested a new way to analyze blood for suspected sepsis.Â
Read More